Results 81 to 90 of about 75,353,973 (171)

Retinal vasculitis after intravitreal aflibercept 8 mg for neovascular age-related macular degeneration

Japanese Journal of Ophthalmology
Abstract Purpose To evaluate short-term outcomes of intravitreal injection of aflibercept 8 mg for neovascular age-related macular degeneration (nAMD). Study design Retrospective, interventional case series.
Hidetaka Matsumoto, Junki Hoshino, Saki Numaga, Kaori Mimura, Yosuke Asatori, Hideo Akiyama   +5 more
openaire   +2 more sources

Short-term intraocular pressure changes following intravitreal injections of aflibercept 8mg versus 2mg: A prospective comparative study

Purpose The increased injection volume of aflibercept 8 mg (0.07 ml versus 0.05 ml) raises theoretical concerns regarding intraocular pressure (IOP) effects.
Hamza Nawaz, Saleh Sahbi, Imran Karim Janmohamed, Anibe Ata, Arsam Mahmood, Haasher Monib, Shabeeba Hannan, Luke Membrey   +7 more
core   +1 more source

Switching to Faricimab or High‐Dose Aflibercept for Neovascular AMD in High‐Demand Patients: Impact on Injection Interval in a Real‐World Cohort

Clinical &Experimental Ophthalmology, Volume 54, Issue 5, Page 724-726, July 2026.
Zachary George Angus, Yin‐Zhi Lee, Sukhpal Singh Sandhu, Robyn Troutbeck, Jonathan Yeoh, Daniel Chiu, Manishka Jayasundera, Jaesser Tan, Sanjeewa Wickremasinghe   +8 more
wiley   +1 more source

Sterile endophthalmitis following same-day intravitreal aflibercept 8 mg injections: a single-center observational study

Background Aflibercept 8 mg was developed to extend treatment intervals in neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). Although pivotal trials reported low rates of intraocular inflammation (IOI), post-marketing
Christos Papadimitriou, Daniel Meller, Fotios Papandreou, Menelaos Papadimitriou, Vasiliki Chioti   +4 more
core   +1 more source

Preclinical Investigations of Intravitreal Ziv-Aflibercept

, 2014
BACKGROUND and OBJECTIVE: To investigate the retinal safety of intravitreal (IVT) ziv-aflibercept in rabbits.MATERIALS and METHODS: Eighteen rabbits were given an IVT injection of ziv-aflibercept (25 mg/mL) or aflibercept (40 mg/mL) and examined by ...
Gabrielly Maria Denadai Chiarantin, Colicchio, Daniel [UNIFESP], Daniel Colicchio, Eduardo Büchele Rodrigues, Oliveira Dias, Joao Rafael de [UNIFESP], Novais, Eduardo Amorim [UNIFESP], Mariana Maurício Matioli, Verna, Carina [UNIFESP], Meyer, Carsten H. [UNIFESP], Tenorio Barros, Nilana Meza [UNIFESP], Farah, Michel Eid [UNIFESP], Eduardo Amorim Novais, João Rafael de Oliveira Dias, Carina Verna, Matioli, Mariana Mauricio [UNIFESP], Badaro, Emmerson [UNIFESP], Denadai Chiarantin, Gabrielly Maria [UNIFESP], Rodrigues, Eduardo Buchele [UNIFESP], Nilana Meza Tenório Barros, Carsten H. Meyer, Fernando Marcondes Penha, Penha, Fernando Marcondes [UNIFESP], Michel Eid Farah, Emmerson Badaró   +23 more
core   +1 more source

Fellow-eye effect of intravitreal aflibercept 8mg in a patient with bilateral refractory nAMD: a case report and literature review

BMC Ophthalmology
Background Intravitreal anti–vascular endothelial growth factor (anti-VEGF) therapy remains first-line therapy for the treatment of neovascular age-related macular degeneration (nAMD), but the high frequency of injections imposes a substantial burden on ...
Jingfa Zhang, Fan Zhang, Ping Wang, Bo Lin, Mingming Yang, Qingshan Chen   +5 more
doaj   +1 more source

Aflibercept for clinically significant diabetic macular edema: 12-month results in daily clinical practice

, 2018
Rafael Campos Polo, Consuelo Rubio Sánchez, Diego Manuel García Guisado, María José Díaz Luque Unit of Retina, Department of Ophthalmology, Hospital Virgen del Puerto, Plasencia, Cáceres, Spain Purpose: To ...
Rubio Sánchez C, Garcia Guisado DM, Campos Polo R, Díaz Luque MJ   +3 more
core  

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema

, 2017
Sameh Mosaad Fouda, Ahmed M Bahgat Department of Ophthalmology, Faculty of Medicine, Zagazig University, Zagazig, Egypt Purpose: The purpose of this study was to compare the efficacy of intravitreal aflibercept and ranibizumab in the treatment of ...
Bahgat AM, Fouda SM
core  

Noninfectious Intraocular Inflammation After Intravitreal Aflibercept.

IMPORTANCE: Aflibercept, 8 mg, is an anti-vascular endothelial growth factor (VEGF) formulation for neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME).
Binder, Karoline E;Bleidißel, Nathalie;Charbel Issa, Peter;Maier, Mathias;Coulibaly, Leonard M
core   +1 more source

Clinical experience with fixed bimonthly aflibercept dosing in treatment-experienced patients with neovascular age-related macular degeneration

, 2015
Arshad M Khanani Sierra Eye Associates, Reno, NV, USA Purpose: To evaluate the durability of fixed bimonthly dosing of intravitreal aflibercept for neovascular age-related macular degeneration.Methods: Records of 16 patients were retrospectively ...
Khanani AM
core